Progression of HIV infection is associated with HLA-DQ antigens in Caucasians and African Americans. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Progression of HIV infection is associated with HLA-DQ antigens in Caucasians and African Americans.

Pathobiology. 1995;63(1):22-41. Unique Identifier : AIDSLINE MED/96055646
Brackin MN; Lewis RE; Brackin BT; Achord A; Henderson H; Crawford M; Cruse JM; Department of Pathology, University of Mississippi Medical; Center, Jackson 39216, USA.


Abstract: In our previous work with human leukocyte antigen (HLA) association in human immunodeficiency virus (HIV) infection, African Americans (Afr Ams) and Caucasians (Caucs) exhibited HLA markers that were associated with protection or disease. The present study was designed to establish if HLAs were associated with the severity of HIV infection and progression to AIDS in Afr Am and Cauc adults. The frequency of serologically determined antigens (Ags) in the regional control population was compared to the HIV-infected population and the HIV-infected slow progressors were compared to rapid progressors by race. chi 2 analysis with Bonferroni adjustment, Kaplan-Meier survival analysis, linear logistic regression, Cox model of proportional hazards and standardized deltas were applied as applicable. Immune parameters were monitored over a mean follow-up period of 23 +/- 2 months for Afr Ams (n = 35) and 25 +/- 5 months for Caucs (n = 24). A better prognosis in the HIV+Afr Am group was associated with HLA-DQ1 with a risk ratio of 0.295. In the HIV+Cauc group, a preferable prognosis was associated with HLA-DQ3 with a risk ratio of 0.11, and a poor prognosis was associated with HLA-DQ2 with a risk ratio of 7. Afr Am haplotypes that appeared to have the greatest association with rapid progression of HIV infection were A69(28)-B40 and related haplotypes as well as B12-DR14(6). Cauc haplotypes with the strongest association with rapid and slow progression of HIV infection were A28-B17-DR9 and A30(19)-B67, respectively. The DR Ags of at least one haplotype that led to rapid progression in both races were associated with DQ9(3). An 'immune response' gene (DQ region) may control the progression of HIV infection in adults. The rapidly progressive DQ-associated peptide might block the progression of HIV if given as a novel vaccine.
Keywords: Adolescence Adult Alleles Blotting, Western Caucasoid Race/*GENETICS Disease Progression Female HIV Infections/*IMMUNOLOGY/MORTALITY/PHYSIOPATHOLOGY HLA-DQ Antigens/GENETICS/*PHYSIOLOGY Haplotypes Human Linear Models Longitudinal Studies Male Middle Age Negroid Race/*GENETICS Phenotype Severity of Illness Index Support, U.S. Gov't, P.H.S. Survival Analysis T-Lymphocytes/IMMUNOLOGY/PATHOLOGY United States/EPIDEMIOLOGY JOURNAL ARTICLE

KWDadolescenceadultallelesblotting,westerncaucasoidrace/KWDgeneticsdiseaseprogressionfemalehivinfections/KWDimmunology/mortality/physiopathologyhla-dqantigens/genetics/KWDphysiologyhaplotypeshumanlinearmodelslongitudinalstudiesmalemiddleagenegroidrace/KWDgeneticsphenotypeseverityofillnessindexsupport,uKWDsKWDgov't,pKWDhKWDsKWDsurvivalanalysist-lymphocytes/immunology/pathologyunitedstates/epidemiologyjournalarticle
960130
M9610806


Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .